PERCEPTIVE ADVISORS LLC

Q4 2019 13F-HR/A Holdings

Location
New York, NY
Holdings as of
12/31/2019
Date filed
2/19/2020
Form type
13F-HR/A - RESTATEMENT
Num holdings
114
Total value ($000)
$5,034,133
Net value change ($000)
—
New positions
109
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2014 Next filing: 5/18/2020 SEC filing

Snapshot: Change Analysis

Compared to previous filing: —
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Global Blood Therapeutics, Inc. 466,266 —
Mirati Therapeutics, Inc. 412,791 —
NBIX 388,313 —
KOD 263,593 —
IOVA 260,640 —
FOLD 244,789 —
ZOGENIX, INC. 193,358 —
Athenex, Inc. 176,100 —
AMARIN CORP PLC 152,355 —
BBIO 142,273 —
Top Reduces (Value $000, Stocks/ETFs)
—
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 30,927 (0.6% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type